Sofosbuvir, pegylated interferon, and ribavirin for retreatment of hepatitis C virus genotype 1b following sofosbuvir and ledipasvir failure

被引：0
|
作者：
Kalal, Chetan [1 ]
Shukla, Akash [1 ]
Mohanka, Ravi [1 ]
Vora, Mihir [1 ]
Patel, Priyesh [1 ]
Shah, Samir [1 ]
机构：
[1] Global Inst Liver Dis, HPB Surg & Transplantat, 35 E Borges Rd,Hosp Ave, Mumbai 400012, Maharashtra, India
来源：
HEPATOLOGY | 2018年 / 67卷 / 05期
关键词：
VARIANTS;
D O I：
10.1002/hep.29667
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：2049 / 2050
页数：2
相关论文
共 50 条
  • [1] Hepatitis C Genotype 1 Cured With 4 Weeks of Pegylated Interferon, Ribavirin, and Sofosbuvir
    Habibullah, Masud
    Bunim, Ari
    Rubin, Moshe
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2014, 109 : S153 - S153
  • [2] Ledipasvir and sofosbuvir:Interferon free therapy for hepatitis C virus genotype 1 infection
    Yasir Waheed
    [J]. World Journal of Virology, 2015, (01) : 33 - 35
  • [3] Case report: successful retreatment of hepatitis C genotype 1b infection with sofosbuvir
    Safadi, Rifaat
    Noviello, Stephanie
    Boparai, Navdeep
    McPhee, Fiona
    [J]. CLINICAL CASE REPORTS, 2016, 4 (07): : 653 - 656
  • [4] Ledipasvir-sofosbuvir plus ribavirin for patients with genotype 1 hepatitis C virus previously treated in clinical trials of sofosbuvir regimens
    Wyles, David
    Pockros, Paul
    Morelli, Giuseppe
    Younes, Ziad
    Svarovskaia, Evguenia
    Yang, Jenny C.
    Pang, Phillip S.
    Zhu, Yanni
    McHutchison, John G.
    Flamm, Steven
    Lawitz, Eric
    [J]. HEPATOLOGY, 2015, 61 (06) : 1793 - 1797
  • [5] Ledipasvir/Sofosbuvir in the Treatment of Hepatitis C Virus Genotype 6
    Nguyen, Andrew A.
    Weisberg, Ilan
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2015, 110 : S368 - S368
  • [6] Effectiveness of sofosbuvir/pegylated-interferon plus ribavirin in treatment of hepatitis C virus genotype 4 patients
    Abdel-Moneim, Adel
    Abood, Alaa
    Abdel-Gabaar, Mohamed
    Zanaty, Mohamed I.
    Ramadan, Mohamed
    [J]. CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2018, 4 (03) : 191 - 196
  • [7] Retreatment with sofosbuvir/ledipasvir with or without lead-in interferon- injections in patients infected with genotype 1b hepatitis C virus after unsuccessful daclatasvir/asunaprevir therapy
    Uemura, Hayato
    Uchida, Yoshihito
    Kouyama, Jun-ichi
    Naiki, Kayoko
    Yamaba, Shinpei
    Fuchigami, Akira
    Saito, Yoichi
    Shiokawa, Keisuke
    Fujii, Yohei
    Uchiya, Hiroshi
    Nakazawa, Manabu
    Ando, Satsuki
    Nakao, Masamitsu
    Motoya, Daisuke
    Sugawara, Kayoko
    Inao, Mie
    Imai, Yukinori
    Nakayama, Nobuaki
    Tomiya, Tomoaki
    Mochida, Satoshi
    [J]. HEPATOLOGY RESEARCH, 2018, 48 (04) : 233 - 243
  • [8] Sofosbuvir and Ribavirin With or Without Pegylated Interferon for Hepatitis C Genotype 3: A Real World Experience
    Abbas, Zaigham
    Saad, Muhammad
    Nadeem, Ramlah
    Jawed, Fahad
    Abbas, Minaam
    [J]. HEPATITIS MONTHLY, 2017, 17 (04)
  • [9] Role of ledipasvir/sofosbuvir combination for genotype 1 hepatitis C virus infection
    Sundaram, Vinay
    Kowdley, Kris V.
    [J]. HEPATIC MEDICINE-EVIDENCE AND RESEARCH, 2016, 8 : 75 - 80
  • [10] Sustained virologic response after eight weeks of treatment with sofosbuvir, ledipasvir, and ribavirin in a decompensated cirrhotic patient with hepatitis C virus genotype 1b
    Taniyama, Ohki
    Mawatari, Seiichi
    Oda, Kohei
    Tabu, Kazuaki
    Ijuin, Sho
    Kumagai, Kotaro
    Kasai, Ai
    Tashima, Shuzo
    Tamai, Tsutomu
    Moriuchi, Akihiro
    Ido, Akio
    [J]. HEPATOLOGY RESEARCH, 2019, 49 (02) : 239 - 243
12345